Skip to main content
Dara Jospé, Partner | Intellectual Property

Dara Jospé

Partner | Intellectual Property Fasken
Jurisdiction Québec, 2014
Language(s) French, English
Office(s) Montréal
Contact
Share
  • LinkedIn

Overview

Dara Jospé practises law in the area of life sciences, health and food regulation. She advises manufacturers on all stages of the lifecycle of a pharmaceutical product, from conception until it reaches the consumer. In all cases, Dara develops low-risk and creative ways to adjust to the legal prohibitions and policy restrictions while keeping business interests and the safety of patients in mind.

She regularly assists companies with their regulatory and compliance responsibilities, including advising on the launch of a new health product in Canada, reviewing advertising material, developing patient support programs involving healthcare professionals, opining on bribery and corruption concerns and drafting standard operating procedures, among others.

In addition, she provides advice on all drug and medical device pricing and reimbursement questions, including assisting with PMPRB investigations, negotiating and drafting product listing agreements in various provinces and providing public procurement assistance.

Dara also advises clients in the context of health product advertising complaints before Health Canada as well as the Pharmaceutical Advertising Acceptance Board and Advertising Standards Canada.

She is frequently involved in Health Canada investigations and recalls. She helps to guide companies through field actions and provides strategic advice to save time, effort and costs for her clients.

Achievements

Client Work

  • BDC Capital completed significant minority investment in The Dissan Group, [Deal - BDC Capital], Significant minority investment by BDC Capital in The Dissan Group.
  • MY01 raises US$ 12.5 million Series A funding round to accelerate its growth, [Deal - Investissement Québec, Desjardins et Fondaction], Series A funding round for MY01.
  • Functionalab completes merger with FYi Medical Aesthetics, creating the largest network of premium aesthetic medicine clinics in Canada, [Deal - Functionalab Inc.], Merger leading to the creation of the largest network of premium aesthetic medicine clinics in Canada.
  • West Penetone Canada acquires Unica Canada, [Deal - West Penetone Inc.], Acquisition of Unica Canada by West Penetone Canada.
  • Advent International acquires leading specialty chemicals solutions provider Caldic from Goldman Sachs Asset Management, [Deal - Advent International], Advent International is one of the largest and most experienced global private equity investors.
  • Bain Capital Private Equity acquires Dessert Holdings, a leading premium dessert company, [Deal - Bain Capital LP], Bain Capital Private Equity acquires Dessert Holdings
  • Champlain and Gefco acquire Naya Waters from L Catterton Partners, [Deal - Champlain Financial Corporation], Champlain and Gefco acquire Naya Waters.
  • Negotiation for the redaction of confidential business information to be released under Health Canada’s Public Release of Clinical Information initiative, [Case - Pharmaceutical manufacturer], Negotiation for the redaction of confidential business information.
  • Constitutional challenge in the Superior Court of Québec attacking controversial amendments to the Patented Medicines Regulations and the validity of the existing PMPRB regime under the Patent Act, [Case - Merck Canada Inc., Janssen Inc., Servier Canada Inc., Boehringer Ingelheim Canada Ltd/Ltée, Bayer Canada Inc., Theratechnologies Inc., and an additional (Confidential) pharmaceutical company], Constitutional challenge in the Superior Court of Québec.

Career & Education

Education

  • JD/LLB University of Ottawa
  • MA, Philosophy York University
  • BA, Philosophy (Hons) with distinction Western University

Knowledge

Events

News

Publications

  • Considering A Telemedicine Or Virtual Care Business In Canada? Here's What You Need To Know Health Law Bulletin, 1/22/2024
  • Health Canada revising medical device premarket guidance framework in response to evolving AI, 11/24/2023
  • Biosimilar Policies in Canada : To Switch or Not to Switch? , 9/29/2022

Speaking Engagements

  • Canadian Legal & Compliance issues, 5/2/2018
  • New Regulations to the Patent Act, 2/26/2018
  • Anti-Bribery and Compliance Update presented during the Legal Training Day, 11/1/2017
Speaker Canadian Legal & Compliance issues
Speaker New Regulations to the Patent Act Structured on-the-job training
Speaker Anti-Bribery and Compliance Update presented during the Legal Training Day Legal Training Day location location Montréal, QC, Canada Fasken

    Subscribe

    Receive email updates from our team

    Subscribe